Phcy-Corp (Piedmont Hospital, Inc.), Atlanta, GA
Is Phcy-Corp (Piedmont Hospital, Inc.) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Phcy-Corp (Piedmont Hospital, Inc.) hold a Georgia pharmacy license?
State board of pharmacy records for Georgia are not checked: no license file or list of board orders was found on the board’s website when checked on November 10, 2026; its license verification is an interactive search.
Has Phcy-Corp (Piedmont Hospital, Inc.) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 state referral letter (Aug 14, 2020) and 1 FMD-145 letter (Aug 14, 2020) for Phcy-Corp (Piedmont Hospital, Inc.). State board of pharmacy records for Georgia are not checked: no license file or list of board orders was found on the board’s website when checked on November 10, 2026; its license verification is an interactive search. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Piedmont Hospital, Inc.; Phcy-Corp
- Location
- Atlanta, GA
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Aug 14, 2020
- FDA Data Dashboard inspections
- No matching site found
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Piedmont Hospital, Inc., (dba Phcy-Corp), a 503A facility, with 3 dated actions.
| Document | |||
|---|---|---|---|
| Aug 14, 2020 | State referral letter | Referral Letter to the Georgia State Board of Pharmacy Issued 08/14/2020 | FDA copy (archived) |
| Aug 14, 2020 | FMD-145 letter | FMD-145 Letter Issued 08/14/2020 | FDA copy (archived) |
| Feb 18, 2020 | Form 483 | 483 Issued 02/18/2020 | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA links 1 Form 483 PDF for Phcy-Corp (Piedmont Hospital, Inc.), but no observation text is shown, for the reasons below.
Linked 483s whose text is not shown
- Feb 18, 2020: FDA document 142274: its numbered observations could not be read reliably from the PDF text.
State board of pharmacy records
State board of pharmacy records for Georgia are not checked: no license file or list of board orders was found on the board’s website when checked on November 10, 2026; its license verification is an interactive search.
This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
Records last pulled Nov 15, 2026. Every entry links to the original public record.